Anticipating that SESNs would likely be involved in mounting survival responses against sustained glucose deprivation, we first measured the expression level changes in SESN1, SESN2, and SESN3 in the HepG2 HCC cell line. The gene discussed is SESN3; the disease is hepatocellular carcinoma.